BSV Group

Mumbai, India Founded: 1971 • Age: 55 yrs Acquired By Mankind Pharma
Provider of drug research development services for pharmaceutical sector
Request Access

About BSV Group

BSV Group is a company based in Mumbai (India) founded in 1971 was acquired by Mankind Pharma in July 2024.. BSV Group has raised $18.15 million across 2 funding rounds from investors including Kotak Mahindra Bank, Mankind Pharma and Orbimed. BSV Group has completed 2 acquisitions, including Firstline and Genomicks. BSV Group offers products and services including Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH. BSV Group operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bharat Serums And Vaccines Limited
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $126.6 M (USD)
    2.67
    as on Mar 31, 2021
  • Net Profit
    $13.47 M (USD)
    93.98
    as on Mar 31, 2021
  • EBITDA
    $21.01 M (USD)
    51.86
    as on Mar 31, 2021
  • Total Equity Funding
    $18.15 M (USD)

    in 2 rounds

  • Latest Funding Round
    $9.39 M (USD), Private Equity Round

    Mar 31, 2010

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Firstline

    & 1 more

  • Acquired by
    Mankind Pharma

    & 1 more

    (Jul 25, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BSV Group

BSV Group offers a comprehensive portfolio of products and services, including Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Recombinant Anti Rh(o)-D Immunoglobin for treating Rh incompatibility.

World's first biotech antibody for Rh incompatibility management.

Inhibitor used in critical care for inflammatory conditions.

Assists in fertility treatments for reproductive health issues.

Funding Insights of BSV Group

BSV Group has successfully raised a total of $18.15M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $9.39 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Private Equity Round — $9.4M
  • First Round

    (21 Nov 2008)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2010 Amount Private Equity Round - BSV Group Valuation Orbimed
Nov, 2008 Amount Private Equity Round - BSV Group Valuation Kotak Mahindra Bank
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BSV Group

BSV Group has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kotak Mahindra Bank, Mankind Pharma and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
Private equity firm focused on multiple sectors
Founded Year Domain Location
Commercial banking services are offered to corporate and retail customers.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BSV Group

BSV Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Firstline and Genomicks. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Medicines and diagnostic kits for fertility treatments are developed.
2016
Distributor of diversified drugs
2007
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - BSV Group

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bsv Group Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BSV Group

BSV Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceutical products are manufactured and marketed worldwide.
domain founded_year HQ Location
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
domain founded_year HQ Location
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
domain founded_year HQ Location
Traditional pharmaceutical medicines are developed for multiple health fields.
domain founded_year HQ Location
Developer of drugs for the treatment of multiple disorders
domain founded_year HQ Location
Biopharmaceutical research and drug development are conducted globally by AbbVie.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bsv Group

Frequently Asked Questions about BSV Group

When was BSV Group founded?

BSV Group was founded in 1971 and raised its 1st funding round 37 years after it was founded.

Where is BSV Group located?

BSV Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Who is the current CEO of BSV Group?

Sanjiv Navangul is the current CEO of BSV Group.

Is BSV Group a funded company?

BSV Group is a funded company, having raised a total of $18.15M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $8.77M, raised on Nov 21, 2008.

What is the annual revenue of BSV Group?

Annual revenue of BSV Group is $126.6M as on Mar 31, 2021.

What does BSV Group do?

BSV Group, established in 1971 and currently in Acquired stage, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drug research development services for pharmaceutical sector. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of BSV Group?

BSV Group's top competitors include Merck, Roivant Sciences and AbbVie.

What products or services does BSV Group offer?

BSV Group offers Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH.

How many acquisitions has BSV Group made?

BSV Group has made 2 acquisitions, including Firstline, and Genomicks.

Who are BSV Group's investors?

BSV Group has 4 investors. Key investors include Kotak Mahindra Bank, Mankind Pharma, Orbimed, and Advent International.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available